Arcturis and Oxford University Hospitals NHS Foundation Trust announce 3-year programme to deliver highly enriched Real-World Data supporting generation of evidence for the development and approval of novel cancer therapies.
2024年5月3日 - 7:05PM
ビジネスワイヤ(英語)
Arcturis Data Limited (“Arcturis”), a UK leader in Real World
Data and Evidence, and Oxford University Hospitals NHS Foundation
Trust (“OUH”) a global exemplar in clinical, research and digital
health excellence, announce today that they are to embark on a
focussed initiative to develop deep, multi-modal data to enable
researchers to assess the benefit of standard and new treatment
options for cancer patients.
The programme of works builds on the success of Arcturis and
OUH’s long-standing multi-disease strategic research partnership,
and represents significant innovation at the convergence of
technology, informatics, pharmaceutical research, and clinical
excellence.
OUH will provide Arcturis researchers with access to its deep,
longitudinal anonymised oncology data within the Thames Valley and
Surrey Secure Data Environment for healthcare research (TVS SDE).
This innovative approach will facilitate access to anonymised NHS
data for approved research projects within an NHS-controlled
environment. This programme will enable valuable research and
innovation, delivering benefits to the Health Service, patients,
and the regional economy, whilst rigorously upholding the
confidentiality and privacy of patients.
Kerrie Woods, Director, R&D Clinical Informatics for OUH
commented:
“Arcturis has unique expertise in integrating molecular and
clinical data and curating fit-for-purpose regulatory-grade
research datasets. This will help OUH to enrich its data with
biomarkers derived from unstructured sources such as diagnostic
imaging, free-text reports, sensor data and clinical genetics. This
valuable work will help to improve the quality and completeness of
the data available for world class research, driving real world
impact. With patient consent, we look forward also to augmenting
existing data with novel genomic, transcriptomic and proteomic
analyses, to develop personalised treatments and services. Our
patient and public partners will oversee the work of this ambitious
programme, ensuring a central focus on healthcare improvement and
clinical impact.”
Christie Brooks, Director, Data Strategy & Partnerships
for Arcturis commented:
“Arcturis and OUH are pleased to build upon our longstanding
successful research partnership with this exciting initiative to
deliver a precision approach to cancer evidence generation. The
partnership is committed to enabling new treatment options to be
better evaluated by regulators, data-driven innovation to be more
informed by UK patients’ needs and the NHS to benefit from the
wealth of data that our health system generates.”
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501326828/en/
info@arcturisdata.com